Literature DB >> 12626561

The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets.

Hiroaki Hemmi1, Tsuneyasu Kaisho, Kiyoshi Takeda, Shizuo Akira.   

Abstract

Oligodeoxynucleotides containing unmethylated CpG motifs (CpG DNAs) can function as powerful immune adjuvants by activating APC. Compared with conventional phosphorothioate-backbone CpG DNAs, another type of CpG DNAs, called an A or D type (A/D-type), possesses higher ability to induce IFN-alpha production. Conventional CpG DNAs can exert their activity through Toll-like receptor 9 (TLR9) signaling, which depends on a cytoplasmic adapter, MyD88. However, it remains unknown how A/D-type CpG DNAs exhibit their immunostimulatory function. In this study we have investigated murine dendritic cell (DC) responses to these two distinct CpG DNAs. Not only splenic, but also in vitro bone marrow-derived, DCs could produce larger amounts of IFN-alpha in response to A/D-type CpG DNAs compared with conventional CpG DNAs. This IFN-alpha production was mainly due to the B220(+) DC subset. On the other hand, the B220(-) DC subset responded similarly to both CpG DNAs in terms of costimulatory molecule up-regulation and IL-12 induction. IFN-alpha, but not IL-12, induction was dependent on type I IFN. However, all activities of both CpG DNAs were abolished in TLR9- and MyD88-, but were retained in DNA-PKcs-deficient DCs. This study demonstrates that the TLR9-MyD88 signaling pathway is essential for all DC responses to both types of CpG DNAs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12626561     DOI: 10.4049/jimmunol.170.6.3059

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  88 in total

1.  The dual functions of IL-1 receptor-associated kinase 2 in TLR9-mediated IFN and proinflammatory cytokine production.

Authors:  Youzhong Wan; Tae Whan Kim; Minjia Yu; Hao Zhou; Michifumi Yamashita; Zizhen Kang; Weiguo Yin; Jian-An Wang; James Thomas; Ganes C Sen; George R Stark; Xiaoxia Li
Journal:  J Immunol       Date:  2011-01-26       Impact factor: 5.422

2.  Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides.

Authors:  Arthur M Krieg
Journal:  Curr Oncol Rep       Date:  2004-03       Impact factor: 5.075

Review 3.  Immunogenomics and systems biology of vaccines.

Authors:  Luigi Buonaguro; Bali Pulendran
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

Review 4.  Beneficial effects of exercise on age-related mitochondrial dysfunction and oxidative stress in skeletal muscle.

Authors:  Anna-Maria Joseph; Peter J Adhihetty; Christiaan Leeuwenburgh
Journal:  J Physiol       Date:  2015-11-21       Impact factor: 5.182

5.  Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling.

Authors:  Kenya Honda; Hideyuki Yanai; Tatsuaki Mizutani; Hideo Negishi; Naoya Shimada; Nobutaka Suzuki; Yusuke Ohba; Akinori Takaoka; Wen-Chen Yeh; Tadatsugu Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-18       Impact factor: 11.205

Review 6.  Plasmacytoid dendritic cells: linking innate and adaptive immunity.

Authors:  Kelli McKenna; Anne-Sophie Beignon; Nina Bhardwaj
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

7.  CpG DNA inhibits CD4+CD25+ Treg suppression through direct MyD88-dependent costimulation of effector CD4+ T cells.

Authors:  David F LaRosa; Andrew E Gelman; Adeeb H Rahman; Jidong Zhang; Laurence A Turka; Patrick T Walsh
Journal:  Immunol Lett       Date:  2007-01-18       Impact factor: 3.685

Review 8.  Toll-like receptors and innate immunity.

Authors:  Satoshi Uematsu; Shizuo Akira
Journal:  J Mol Med (Berl)       Date:  2006-09       Impact factor: 4.599

9.  Dual activation of Toll-like receptors 7 and 9 impairs the efficacy of antitumor vaccines in murine models of metastatic breast cancer.

Authors:  Mariela A Moreno Ayala; María Florencia Gottardo; María Soledad Gori; Alejandro Javier Nicola Candia; Carla Caruso; Andrea De Laurentiis; Mercedes Imsen; Slobodanka Klein; Elisa Bal de Kier Joffé; Gabriela Salamone; Maria G Castro; Adriana Seilicovich; Marianela Candolfi
Journal:  J Cancer Res Clin Oncol       Date:  2017-04-21       Impact factor: 4.553

10.  CpG-ODN enhances ingestion of apoptotic neutrophils by macrophages.

Authors:  Jiong Wang; Wei-Lin Huang; Rong-Yu Liu
Journal:  Clin Exp Med       Date:  2008-10-25       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.